StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

Analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.03 on Monday. Calithera Biosciences has a twelve month low of $0.01 and a twelve month high of $0.50. The business has a fifty day moving average of $0.02 and a 200-day moving average of $0.03.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.